GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Change In Prepaid Assets

Veracyte (FRA:12V) Change In Prepaid Assets : €-0.5 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Veracyte Change In Prepaid Assets?

Veracyte's Change In Prepaid Assets for the quarter that ended in Dec. 2023 was €1.0 Mil. It means Veracyte's Prepaid Assets increased by €1.0 Mil from Sep. 2023 to Dec. 2023 .

Veracyte's Change In Prepaid Assets for the fiscal year that ended in Dec. 2023 was €-0.4 Mil. It means Veracyte's Prepaid Assets declined by €0.4 Mil from Dec. 2022 to Dec. 2023 .

Veracyte Change In Prepaid Assets Historical Data

The historical data trend for Veracyte's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte Change In Prepaid Assets Chart

Veracyte Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Prepaid Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 -0.80 -2.94 1.31 -0.42

Veracyte Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 -2.86 0.49 0.89 1.03

Veracyte Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veracyte Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Veracyte's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Veracyte (FRA:12V) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Change In Prepaid Assets
Comparable Companies
BEAM PTCT SWTX SMMT PNT RYTM IDYA VCEL CPRX ACLX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
VCYT:USA
Address
6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Website
https://www.veracyte.com
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis products.

Veracyte (FRA:12V) Headlines

No Headlines